Polymorphisms in the cathepsin L2 (CTSL2) gene show association with type 1 diabetes and early-onset myasthenia gravis.

Standard

Polymorphisms in the cathepsin L2 (CTSL2) gene show association with type 1 diabetes and early-onset myasthenia gravis. / Viken, Marte K; Sollid, Hege Dahlen; Joner, Geir; Dahl-Jørgensen, Knut; Rønningen, Kjersti S; Undlien, Dag E; Flatø, Berit; Selvaag, Anne M; Førre, Øystein; Kvien, Tore K; Thorsby, Erik; Melms, Arthur; Tolosa, Eva; Lie, Benedicte A.

in: HUM IMMUNOL, Jahrgang 68, Nr. 9, 9, 2007, S. 748-755.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Viken, MK, Sollid, HD, Joner, G, Dahl-Jørgensen, K, Rønningen, KS, Undlien, DE, Flatø, B, Selvaag, AM, Førre, Ø, Kvien, TK, Thorsby, E, Melms, A, Tolosa, E & Lie, BA 2007, 'Polymorphisms in the cathepsin L2 (CTSL2) gene show association with type 1 diabetes and early-onset myasthenia gravis.', HUM IMMUNOL, Jg. 68, Nr. 9, 9, S. 748-755. <http://www.ncbi.nlm.nih.gov/pubmed/17869649?dopt=Citation>

APA

Viken, M. K., Sollid, H. D., Joner, G., Dahl-Jørgensen, K., Rønningen, K. S., Undlien, D. E., Flatø, B., Selvaag, A. M., Førre, Ø., Kvien, T. K., Thorsby, E., Melms, A., Tolosa, E., & Lie, B. A. (2007). Polymorphisms in the cathepsin L2 (CTSL2) gene show association with type 1 diabetes and early-onset myasthenia gravis. HUM IMMUNOL, 68(9), 748-755. [9]. http://www.ncbi.nlm.nih.gov/pubmed/17869649?dopt=Citation

Vancouver

Viken MK, Sollid HD, Joner G, Dahl-Jørgensen K, Rønningen KS, Undlien DE et al. Polymorphisms in the cathepsin L2 (CTSL2) gene show association with type 1 diabetes and early-onset myasthenia gravis. HUM IMMUNOL. 2007;68(9):748-755. 9.

Bibtex

@article{89162d1619e34636803ad0f977799f4d,
title = "Polymorphisms in the cathepsin L2 (CTSL2) gene show association with type 1 diabetes and early-onset myasthenia gravis.",
abstract = "Type 1 diabetes (T1D) is an autoimmune disease characterized by loss of beta cells in the pancreas. The CTSL2 gene encodes the cysteine protease cathepsin V involved in antigen presentation in human cortical thymic epithelial cells, and involvement of the protease in autoimmunity has been suggested. This study aimed to evaluate CTSL2 as a candidate gene for T1D, and test whether the gene predisposes more generally to autoimmune diseases. Four polymorphisms aiming at tagging the CTSL2 locus were genotyped in 421 T1D families, and subsequently in 861 rheumatoid arthritis patients, 530 juvenile idiopathic arthritis patients, and 559 controls of Norwegian origin. Additionally, DNA from 83 German myasthenia gravis (MG) patients and 244 controls were investigated. A polymorphism, rs16919034, situated downstream of CTSL2 was associated with T1D (60.8%T, p = 0.008; p(c) = 0.03). An association with early-onset MG (45% in cases vs 36.6% in controls; p = 0.03) was observed for another polymorphism (rs4361859) situated upstream of the gene, but within the same linkage disequilibrium block. No association was observed in rheumatoid arthritis or juvenile idiopathic arthritis. Our findings suggest that the CTSL2 gene is associated with T1D and with early-onset MG.",
keywords = "Adult, Humans, Male, Female, Adolescent, Child, Child, Preschool, Infant, Age of Onset, Linkage Disequilibrium, *Genetic Predisposition to Disease, *Polymorphism, Single Nucleotide, Diabetes Mellitus, Type 1/*genetics, Cathepsin L, Cathepsins/*genetics, Cysteine Endopeptidases/*genetics, Myasthenia Gravis/epidemiology/*genetics, Adult, Humans, Male, Female, Adolescent, Child, Child, Preschool, Infant, Age of Onset, Linkage Disequilibrium, *Genetic Predisposition to Disease, *Polymorphism, Single Nucleotide, Diabetes Mellitus, Type 1/*genetics, Cathepsin L, Cathepsins/*genetics, Cysteine Endopeptidases/*genetics, Myasthenia Gravis/epidemiology/*genetics",
author = "Viken, {Marte K} and Sollid, {Hege Dahlen} and Geir Joner and Knut Dahl-J{\o}rgensen and R{\o}nningen, {Kjersti S} and Undlien, {Dag E} and Berit Flat{\o} and Selvaag, {Anne M} and {\O}ystein F{\o}rre and Kvien, {Tore K} and Erik Thorsby and Arthur Melms and Eva Tolosa and Lie, {Benedicte A}",
year = "2007",
language = "English",
volume = "68",
pages = "748--755",
journal = "HUM IMMUNOL",
issn = "0198-8859",
publisher = "Elsevier Inc.",
number = "9",

}

RIS

TY - JOUR

T1 - Polymorphisms in the cathepsin L2 (CTSL2) gene show association with type 1 diabetes and early-onset myasthenia gravis.

AU - Viken, Marte K

AU - Sollid, Hege Dahlen

AU - Joner, Geir

AU - Dahl-Jørgensen, Knut

AU - Rønningen, Kjersti S

AU - Undlien, Dag E

AU - Flatø, Berit

AU - Selvaag, Anne M

AU - Førre, Øystein

AU - Kvien, Tore K

AU - Thorsby, Erik

AU - Melms, Arthur

AU - Tolosa, Eva

AU - Lie, Benedicte A

PY - 2007

Y1 - 2007

N2 - Type 1 diabetes (T1D) is an autoimmune disease characterized by loss of beta cells in the pancreas. The CTSL2 gene encodes the cysteine protease cathepsin V involved in antigen presentation in human cortical thymic epithelial cells, and involvement of the protease in autoimmunity has been suggested. This study aimed to evaluate CTSL2 as a candidate gene for T1D, and test whether the gene predisposes more generally to autoimmune diseases. Four polymorphisms aiming at tagging the CTSL2 locus were genotyped in 421 T1D families, and subsequently in 861 rheumatoid arthritis patients, 530 juvenile idiopathic arthritis patients, and 559 controls of Norwegian origin. Additionally, DNA from 83 German myasthenia gravis (MG) patients and 244 controls were investigated. A polymorphism, rs16919034, situated downstream of CTSL2 was associated with T1D (60.8%T, p = 0.008; p(c) = 0.03). An association with early-onset MG (45% in cases vs 36.6% in controls; p = 0.03) was observed for another polymorphism (rs4361859) situated upstream of the gene, but within the same linkage disequilibrium block. No association was observed in rheumatoid arthritis or juvenile idiopathic arthritis. Our findings suggest that the CTSL2 gene is associated with T1D and with early-onset MG.

AB - Type 1 diabetes (T1D) is an autoimmune disease characterized by loss of beta cells in the pancreas. The CTSL2 gene encodes the cysteine protease cathepsin V involved in antigen presentation in human cortical thymic epithelial cells, and involvement of the protease in autoimmunity has been suggested. This study aimed to evaluate CTSL2 as a candidate gene for T1D, and test whether the gene predisposes more generally to autoimmune diseases. Four polymorphisms aiming at tagging the CTSL2 locus were genotyped in 421 T1D families, and subsequently in 861 rheumatoid arthritis patients, 530 juvenile idiopathic arthritis patients, and 559 controls of Norwegian origin. Additionally, DNA from 83 German myasthenia gravis (MG) patients and 244 controls were investigated. A polymorphism, rs16919034, situated downstream of CTSL2 was associated with T1D (60.8%T, p = 0.008; p(c) = 0.03). An association with early-onset MG (45% in cases vs 36.6% in controls; p = 0.03) was observed for another polymorphism (rs4361859) situated upstream of the gene, but within the same linkage disequilibrium block. No association was observed in rheumatoid arthritis or juvenile idiopathic arthritis. Our findings suggest that the CTSL2 gene is associated with T1D and with early-onset MG.

KW - Adult

KW - Humans

KW - Male

KW - Female

KW - Adolescent

KW - Child

KW - Child, Preschool

KW - Infant

KW - Age of Onset

KW - Linkage Disequilibrium

KW - Genetic Predisposition to Disease

KW - Polymorphism, Single Nucleotide

KW - Diabetes Mellitus, Type 1/genetics

KW - Cathepsin L

KW - Cathepsins/genetics

KW - Cysteine Endopeptidases/genetics

KW - Myasthenia Gravis/epidemiology/genetics

KW - Adult

KW - Humans

KW - Male

KW - Female

KW - Adolescent

KW - Child

KW - Child, Preschool

KW - Infant

KW - Age of Onset

KW - Linkage Disequilibrium

KW - Genetic Predisposition to Disease

KW - Polymorphism, Single Nucleotide

KW - Diabetes Mellitus, Type 1/genetics

KW - Cathepsin L

KW - Cathepsins/genetics

KW - Cysteine Endopeptidases/genetics

KW - Myasthenia Gravis/epidemiology/genetics

M3 - SCORING: Journal article

VL - 68

SP - 748

EP - 755

JO - HUM IMMUNOL

JF - HUM IMMUNOL

SN - 0198-8859

IS - 9

M1 - 9

ER -